Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Evoq Remedies Ltd (NSE: EVOQ), ISIN INE0JVD01011 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
EVOQ last traded at ₹1.53 (-4.97%), with a 52-week range of ₹1.35 to ₹4.70 (as of 5 Nov 2026).
Shareholding as of Mar 2026: promoters 0.02%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 9/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.